A systematic review of secretin for children with autism spectrum disorders
Open accessAbstract
CONTEXT: As many as 1 in every 110 children in the United States has an autism spectrum disorder (ASD). Secretin is 1 of many medical treatments studied for treating the symptoms of ASDs, but there is currently no consensus regarding which interventions are most effective. OBJECTIVE: To systematically review evidence regarding the use of secretin in children with ASDs who are aged 12 years and younger. METHODS: We searched the Medline, PsycINFO, and ERIC (Education Resources Information Center) databases from 2000 to May 2010 and reference lists of included articles. Two reviewers independently assessed each study against predetermined inclusion/exclusion criteria. Two reviewers independently extracted data regarding participant and intervention characteristics, assessment techniques, and outcomes and assigned overall quality and strength-of-evidence ratings on the basis of predetermined criteria. RESULTS: Evidence from 7 randomized controlled trials supports a lack of effectiveness of secretin for the treatment of ASD symptoms including language and communication impairment, symptom severity, and cognitive and social skill deficits. No studies have resulted in significantly greater improvements in measures of language, cognition, or autistic symptoms when compared with placebo; study authors who reported improvement over time did so equally for both the intervention and placebo groups. CONCLUSIONS: Secretin has been studied extensively in multiple randomized controlled trials, and there is clear evidence that it lacks benefit. The studies of secretin included in this review uniformly point to a lack of significant impact of secretin in the treatment of ASD symptoms. Given the high strength of evidence for a lack of effectiveness, secretin as a treatment approach for ASDs warrants no further study.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Efficacy-based studies have failed to demonstrate an impactful benefit of pharmacotherapy to the underlying disorder in ASD.
“Efficacy-based studies have failed to demonstrate an impactful benefit of pharmacotherapy to the underlying disorder [84, 85, 83].”
From Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders (2018) · cites this paper as [84]
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842 · see citing works
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,767 · see citing works
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065 · see citing works
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., Pickles, A., & Rutter, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005592401947 · Cited by 7,520 · see citing works
Owens, D. K., Lohr, K. N., Atkins, D., Treadwell, J. R., Reston, J. T., Bass, E. B., Chang, S., & Helfand, M. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.009 · Cited by 513 · see citing works
Horváth, K., Stefanatos, G. A., Sokolski, K. N., Wachtel, R., Nabors, L., & Tildón, J. T. (1998) · PubMed · Cited by 248 · see citing works
Intravenous secretin for autism spectrum disorders (ASD)
Williams, K., Wray, J. A., & Wheeler, D. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003495.pub3 · Cited by 128 · see citing works
Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism
Owley, T. B., McMahon, W., Cook, E. H., Laulhere, T. M., South, M., Mays, L. Z., Shernoff, E. S., Lainhart, J. E., Modahl, C., Corsello, C. M., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200111000-00009 · Cited by 121 · see citing works
Secretin and Autism: A Two-Part Clinical Investigation
Chez, M. G., Buchanan, C. P., Bagan, B. T., Hammer, M. S., McCarthy, K. S., Ovrutskaya, I., Nowinski, C. V., & Cohen, Z. S. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005443119324 · Cited by 94 · see citing works
Secretin: specific binding to rat brain membranes
Fremeau, R. T., Rt, J., Charlton, C., Miller, R. S., O'Donohue, T., & Moody, T. (1983) · Journal of Neuroscience · doi:10.1523/jneurosci.03-08-01620.1983 · Cited by 82 · see citing works
Roberts, W., Weaver, L., Brian, J. A., Bryson, S., Emelianova, S., Griffiths, A.-M., Modi, B. M., Yim, C. Y., Wolpin, J., & Koren, G. (2001) · PEDIATRICS · doi:10.1542/peds.107.5.e71 · Cited by 79 · see citing works
Effect of secretin on children with autism: a randomized controlled trial
Geier, J. D., Ho, H. H., Auersperg, E., Doyle, D., Eaves, L., Matsuba, C., Orrbine, E., Pham, B., & Whiting, S. E. (2001) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200001481 · Cited by 78 · see citing works
Unis, A. S., MUNSON, J. A., Rogers, S. J., GOLDSON, E., Osterling, J., Gabriels, R. L., ABBOTT, R. D., & Dawson, G. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200211000-00012 · Cited by 65 · see citing works
Coniglio, S. J., Lewis, J. D., Lang, C. B., Burns, T. G., Subhani-Siddique, R., Weintraub, A. H., Schub, H. S., & Holden, E. W. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112474 · Cited by 63 · see citing works
Intravenous secretin for autism spectrum disorder
Williams, K. J., Wray, J., & Wheeler, D. M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003495.pub2 · Cited by 62 · see citing works
Levy, S. E. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.8.731 · Cited by 52 · see citing works
Effect of secretin on children with autism: a randomized controlled trial
Geier, J. D., Ho, H. H., Auersperg, E., David Doyle, M. D., Eaves, L. C., Orrbine, E., & Whiting, S. E. (2000) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2000.tb00692.x · Cited by 52 · see citing works
Therapies for Children with Autism Spectrum Disorders
Zachary Warren, P. D. (2013) · Brown Digital Repository · doi:10.7301/z01z429d · Cited by 52 · see citing works
Secretin modulation of behavioral and physiological functions in the rat
Charlton, C. G., Miller, R. L., Crawley, J. N., Handelmann, G. E., & O’Donohue, T. L. (1983) · Peptides · doi:10.1016/0196-9781(83)90029-3 · Cited by 50 · see citing works
Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism
Molloy, C. A., Manning‐Courtney, P., Swayne, S., Bean, J. A., Brown, J. M., Murray, D. S., Kinsman, A. M., Brasington, M., & Ulrich, C. D. (2002) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1021202930206 · Cited by 37 · see citing works
Somatostatin versus Secretin in the Treatment of Actively Bleeding Gastric Erosions
Tulassay, Z., Bodnár, A., Farkas, I., Papp, J., & Gupta, R. K. (2009) · Digestion · doi:10.1159/000200900 · Cited by 7 · see citing works
Watanabe, Y., Tsumura, H., & Sasaki, H. (1991) · Gastroenterologia Japonica · doi:10.1007/bf02779272 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lai, M.-C., Lombardo, M. V., & Baron-Cohen, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61539-1 · Cited by 2,371 · see citing works
A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0427 · Cited by 356 · see citing works
Self-citationIntravenous secretin for autism spectrum disorders (ASD)
Williams, K., Wray, J. A., & Wheeler, D. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003495.pub3 · Cited by 128 · see citing works
Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders
Israelyan, N., & Margolis, K. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.020 · Cited by 122 · see citing works
Campbell, A. S., Needham, B. D., Meyer, C. R., Tan, J. H. J., Conrad, M. C., Preston, G. M., Bolognani, F., Rao, S. G., Heussler, H., Griffith, R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01683-9 · Cited by 109 · see citing works
A Review of Complementary and Alternative Treatments for Autism Spectrum Disorders
Lofthouse, N., Hendren, R. L., Hurt, E. A., Arnold, L. E., & Butter, E. M. (2012) · Autism Research and Treatment · doi:10.1155/2012/870391 · Cited by 98 · see citing works
Reprint of: Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders
Israelyan, N., & Margolis, K. G. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.023 · Cited by 87 · see citing works
King, B. H., Dukes, K. A., Donnelly, C. L., Sikich, L., McCracken, J. T., Scahill, L. D., Hollander, E., Bregman, J. D., Anagnostou, E. A., Robinson, F., et al. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.2698 · Cited by 70 · see citing works
Psychopharmacology of Autism Spectrum Disorders
Kaplan, G., & McCracken, J. T. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.10.005 · Cited by 62 · see citing works
Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling
Danhof, H. A., Lee, J., Thapa, A., Britton, R. A., & Rienzi, S. C. D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2256043 · Cited by 57 · see citing works
Iffland, M., Livingstone, N., Jorgensen, M. L., Hazell, P., & Gillies, D. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011769.pub2 · Cited by 55 · see citing works
Huang, A., Seshadri, K., Matthews, T. A., & Ostfeld, B. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2012.0640 · Cited by 46 · see citing works
Bertelli, M. O., Azeem, M. W., Underwood, L., Scattoni, M. L., Persico, A. M., Ricciardello, A., Sappok, T., Bergmann, T. J., Keller, R., Bianco, A., et al. (2022) · Springer eBooks · doi:10.1007/978-3-319-95720-3_16 · Cited by 42 · see citing works
Dietary Approaches to the Management of Autism Spectrum Disorders
Hartman, R. E., & Patel, D. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_19 · Cited by 35 · see citing works
Anagnostou, E. A., & Hansen, R. L. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834cba3e · Cited by 30 · see citing works
Early Identification and Early Treatment of Autism Spectrum Disorder
Rogers, S. J., & Talbott, M. R. (2016) · International review of research in developmental disabilities · doi:10.1016/bs.irrdd.2016.05.004 · Cited by 30 · see citing works
Complementary and Alternative Treatments for Autism Part 1: Evidence-Supported Treatments
Bent, S., & Hendren, R. L. (2015) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2015.17.4.sect1-1504 · Cited by 19 · see citing works
The importance of autism research
Thurm, A. E., & Swedo, S. E. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/athurm · Cited by 19 · see citing works
Psychotropic Medications as Treatments for People with Autism Spectrum Disorder
Poling, A. D., Ehrhardt, K. E., & Li, A. (2017) · Autism and child psychopathology series · doi:10.1007/978-3-319-61738-1_25 · Cited by 17 · see citing works
The Central Mechanisms of Secretin in Regulating Multiple Behaviors
Zhang, L., & Chow, B. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00077 · Cited by 17 · see citing works
Camarata, S. (2014) · International Journal of Speech-Language Pathology · doi:10.3109/17549507.2013.864708 · Cited by 15 · see citing works
Coury, D. L., Swedo, S. E., Thurm, A. E., Miller, D. T., Veenstra-VanderWeele, J. M., Carbone, P. S., & Taylor, J. L. (2014) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2013.12.002 · Cited by 15 · see citing works
Freitag, C. M., & Jarczok, T. A. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_13 · Cited by 13 · see citing works
Unwanted Interactions Among Psychotropic Drugs and Other Treatments for Autism Spectrum Disorders
Theoharides, T. C., & Asadi, S. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31825e00e4 · Cited by 13 · see citing works
The Potential Role of Gut Peptide Hormones in Autism Spectrum Disorder
Qi, X., & Zhang, L. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00073 · Cited by 12 · see citing works
Trauner, D. A., Umlauf, A., Grelotti, D. J., Fitzgerald, R. L., Hannawi, A. P., Marcotte, T. D., Knight, C., Smith, L., Paez, G., Crowhurst, J., et al. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-06884-y · Cited by 11 · see citing works
Newspaper Coverage of Autism Treatment in Canada: 10-Year Trends (2004–2013)
Lanovaz, M. J., Dufour, M., & Shah, S. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000706 · Cited by 11 · see citing works
Elizabeth, M., & Zabielski, R. (2013) · InTech eBooks · doi:10.5772/55425 · Cited by 11 · see citing works
Davoody, S., Mansouri, M., & Houri, H. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110143 · Cited by 6 · see citing works
Evans, P., Golla, S., & Morris, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00018-8 · Cited by 6 · see citing works
Freitag, C. M., & Jarczok, T. A. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_13 · Cited by 6 · see citing works
Smith, T. H., Oakes, L. A., & Selver, K. (2014) · doi:10.1002/9781118911389.hautc46 · Cited by 6 · see citing works
History of Non-Evidence-Based Practices for Individuals Diagnosed with ASD
Kryszak, E. M., & Mulick, J. A. (2022) · Autism and child psychopathology series · doi:10.1007/978-3-030-96478-8_3 · Cited by 5 · see citing works
A Phase II Trial of Human Secretin Infusion for Refractory Type B Pain in Chronic Pancreatitis
Levenick, J. M., Andrews, C. L., Purich, E. D., Gordon, S. R., & Gardner, T. B. (2013) · Pancreas · doi:10.1097/mpa.0b013e318273f3ec · Cited by 5 · see citing works
Becker, M. M., Riesgo, R. D. S., Roesler, R., Bosa, C. A., Ohlweiler, L., Backes, B., Endres, R. G., Zanon, R. B., Marchezan, J., & Schwartsmann, G. (2016) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000165 · Cited by 5 · see citing works
Empowering Families in the Treatment of Autism
Elder, J. H. (2013) · InTech eBooks · doi:10.5772/54303 · Cited by 5 · see citing works
Gene therapy as an emerging treatment for Scn2a mutation-induced autism spectrum disorders
Ghosh, A., Nadella, N., Monaghan, A. P., & Chu, X. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.004 · Cited by 5 · see citing works
Pharmacological Interventions for Adults with Autism Spectrum Disorder
Rotta, K., VanDerwall, R., Ehrhardt, K. E., & Poling, A. D. (2022) · Autism and child psychopathology series · doi:10.1007/978-3-030-98507-3_17 · Cited by 4 · see citing works
Bernier, R., & Dawson, G. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy303 · Cited by 3 · see citing works
Autism spectrum disorders - first indicators and school age outcome
Olsson, M. B. (2016) · Cited by 2 · see citing works
Do We Have Evidence for Dietary and Nutritional Interventions for Autism Spectrum Disorder?
Weitlauf, A. S., Goode, R. H., & Warren, Z. E. (2019) · PEDIATRICS · doi:10.1542/peds.2019-1680 · Cited by 2 · see citing works
Review: secretin is not effective for the treatment of children with autism spectrum disorders
Welch, M. G. (2011) · Evidence-Based Mental Health · doi:10.1136/ebmh.2011.100131 · Cited by 2 · see citing works
A Systematic Review of Secretin for Children With Autism Spectrum Disorders
Mack, A. H. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2011.08.100 · Cited by 2 · see citing works
Psychopharmacology of Autism Spectrum Disorders
Mooney, L. N., Fosdick, C., & Erickson, C. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108297769.008 · Cited by 2 · see citing works
Ng, S., Cheng, C. Y. Y., & Chow, B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00123-8 · Cited by 2 · see citing works
Controversial Treatments for Autism Spectrum Disorders
Fodstad, J. C., Raches, C. M., & Hines, E. N. (2024) · Autism and child psychopathology series · doi:10.1007/978-3-031-64499-3_23 · Cited by 1 · see citing works
Miller, L. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00179-2 · Cited by 1 · see citing works
A Review for Existing Complementary and Alternative Medical Therapies for Autism Spectrum Disorder
Yin, X. (2020) · Journal of Psychological Research · doi:10.30564/jpr.v2i4.2236 · Cited by 1 · see citing works
Psychosomatische und psychiatrische Erkrankungen
Weber, P. (2013) · Springer eBooks · doi:10.1007/978-3-642-24710-1_45
Bent, S., & Hendren, R. L. (2015)
Neuropsychologie et remédiations des troubles du spectre de l’autisme
Bizet, É., & de la Rosa, S. M. (2018) · De Boeck Supérieur eBooks · doi:10.3917/dbu.breti.2018.01.0063
Welcome, M. O. (2018) · Springer eBooks · doi:10.1007/978-3-319-91056-7_8
Williams, J. A. (2013) · doi:10.3998/panc.2013.5
Boreman, C. D. (2016) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2016.01.002
Rosa, S. L. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5199-1
Rosa, S. L. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62345-6_5199
Freitag, C. M., & Jarczok, T. A. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_13
Etiological and Co-etiological Factors of Autism
Salvo, M. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-68338-1_11
Considering Emerging, Complementary, and Alternative Treatments
Øien, R. A., Nordahl‐Hansen, A., Skarbek, S., Tolkin, S., & Volkmar, F. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-78143-8_15
Johnson, B. P., Bellgrove, M. A., & Williams, K. J. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197635841.003.0032
Ineffective and Harmful Treatments
Kryszak, E. M., & Mulick, J. A. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197635841.003.0038
Psychotropic Medications as Treatments for People with Autism Spectrum Disorders
Li, A., Poling, A. D., & Ehrhardt, K. E. (2025) · Autism and child psychopathology series · doi:10.1007/978-3-032-01237-1_16
Chu, Z., Fan, X., Du, L., Cao, Y., Liu, J., Meng, F., Zhao, D., Wang, W., Zhang, M., Wang, D., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118075
Vastrad, B. M., Vastrad, C. M., & Patil, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10751405/v1
- Authors
- Krishnaswami, S., McPheeters, M. L., & Veenstra-VanderWeele, J.
- Affiliations
- Vanderbilt Evidence-Based Practice Center, Institute for Medicine and Public Health, and
- Vanderbilt University (US)
- Corresponding author
- McPheeters, Melissa L.
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2011-05-01
- Volume
- 127
- Issue
- 5
- Pages
- e1322-e1325
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC3387870
- OpenAlex
- W2127867162
- Cited by
- 64
- References
- 22
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 6 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 3 · 2014: 6 · 2013: 10 · 2012: 6
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (HHSA 290 2007 10065 I)
- National Institute of Mental Health
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- secretin, autism spectrum disorder, children, treatment effectiveness, symptom severity, cognitive impairment, social skills deficits, placebo comparison, randomized controlled trials
- MeSH terms
- Child, Child Development Disorders, Pervasive, Child, Preschool, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Male, Secretin, Severity of Illness Index, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
